AACR shared on LinkedIn:
“Immunotherapy for cancer has come a long way, [but] it is not good enough. We have to do more.”
The AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 23-26, Los Angeles), chaired by Antoni Ribas, is designed to foster the next generation of immunotherapies for cancer.
Submit an abstract by November 13. ”